TransMedics (TMDX) IPO Opens 27% Higher

Today's IPO for TransMedics Group (NASDAQ: TMDX) opened for trading at $20.25 pricing of its upsized initial public offering of 5,690,000 shares of its common stock at a price to the public of $16.00 per share.

Morgan Stanley and J.P. Morgan are acting as joint lead book-running managers for the offering. Cowen and Canaccord Genuity are acting as co-managers for the offering.

TransMedics is the world’s leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation, and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

You May Also Be Interested In

• SK hynix files for Nasdaq IPO under ticker symbol SKHY
• CopperTech Metals files for IPO on NYSE under ticker CUX
• EG Group Is Said To Confidentially File For $1 Billion UU IPO - Bloomberg